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ABSTRACT 
 
Background: Breast lesions are a common occurrence in women of all age groups. Geographically, the occurrence 
of non-neoplastic and neoplastic lesions varies. The accurate diagnosis of individual cases has garnered importance 
over the years owing to a steep rise in neoplastic occurrences. Fine needle aspiration cytology (FNAC) has been a 
useful component in the diagnostic panel of palpable breast lesions. Materials & Method: Present work was carried 
out in the department of pathology, of a tertiary rural care hospital, over a period of one year from January 2015 to 
December 2015. FNAC was performed on all the patients presenting with palpable breast lesions. Smears were 
prepared and studied under light microscopy under clinical and radiological guidance. All the data was then studied 
and analyzed. Results: FNAC was performed on 171 cases. Cytologically, we categorized all the lesions as 
infectious/ inflammatory with 19 (11.11%), benign 76(44.44%), suspicious for malignancy 04 (2.33%), malignant 
with 62 (36.25%) and 09 (5.26%) unsatisfactory cases. Mean age of presentation was 45.5 years with left breast 
being more commonly involved. Histopathological correlation was possible in 111 (64.91%) cases. High sensitivity 
and specificity was observed. Conclusion: FNAC still remains a reliable, cost-effective, patient friendly and 
minimally invasive method. The application of FNAC as a diagnostic modality in palpable breast lesions should be 
all the more encouraged in routine practice. 
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Introduction 
 
Lesions in the breast are not an uncommon occurrence 
in women throughout the world. FNAC for quite some 
time has been one of component of the ‘triple test’ that 
is employed in diagnosis of all breast lesions and 
exclusively malignancies [1]. Although, majority of the 
breast lumps prove to be benign, there is a definite rise 
in premalignant and malignant lesions [2]. Being a 
simple, minimally invasive and quick investigation, 
FNAC has reserved a place as a reliable diagnostic 
modality for palpable breast lesions. Next to cervical 
cancer, breast malignancies are second most common 
malignancies amongst females in India[3].Core needle 
biopsy is being increasingly used now-a-days. 
However, high cost, long processing period and other 
disadvantages such as possibility of tumor seeding, 
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haematoma formation and localized pain cannot be 
over looked[4-5]. FNAC is a minimally invasive, 
patient friendly procedure with turnaround time of less 
than a day with almost no complications [6] . Apart 
from frank malignancies FNAC can diagnose an array 
of lesions like atypical lesions, benign lesions such as 
fibroadenoma, phyllodes and cystic lesions such as 
galactocele and fibrocystic disease. A proper diagnosis 
of cytology can definitely avoid unnecessary surgeries 
and provide better health care. 
 
Materials & method 
 
Present work was carried out in the department of 
pathology, of a tertiary rural care hospital, over a 
period of a year from January 2015 to December 2015. 
This study is a descriptive, cross- sectional and 
analytical type of study. FNAC was performed on all 
the patients with palpable breast lumps using a 22-23 
gauge needle, 2-3 passes were performed and material 
was smeared on clean glass slides. Half of the slides 
were air dried and stained with Leishman stain while 
other half of slides were wet fixed with cytofixative 
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(50% Ether and Ethyl alcohol mixture) and stained 
with routine Haematoxylin and Eosin (H&E). After 
processing, slides were examined under light 
microscopy. The final diagnosis was given after 
considering the clinical history and radiological 
investigation. All the breast lesions were then classified 
as inflammatory, infectious, cystic lesions, epithelial 
proliferative lesion with and without atypia, suspicious 
and malignancy. Histopathological correlation was 
done in 111 cases. Sensitivity, specificity, positive and 
negative predictive valves were calculated. 
 
Results 
 
We performed FNAC on 171 patients with breast 
lumps. As expected, majority 168 (98.64%) were 
females and 03 (1.57%) were males. Most common age 
group affected among all cases was 41-50 years with 
37 (21.63%) cases and mean age of presentation being 
45.4 years.[Figure 1]. Left side lesions were most 
frequently encountered with 99 (57.89%) cases and 
right breast was affected in 69 (43.05%) cases. We had 
03 (1.75%) cases of bilateral breast 
involvement.[Figure 2] Upper outer quadrant was most 
commonly affected with 73 (42.69%) cases followed 
by upper inner quadrant with 41 (23.97%) cases. 11 
(6.43%) subareolar masses were observed. Lower 
breast was involved in 44 (25.73%) cases. All four 
quadrants were involved in 04 (2.33%) cases. [Figure 
3].Patients presented with varied signs and symptoms. 
Patients presented with lump in breast with or without 
associated symptoms. Lump with pain was the most 
common symptom seen in 95 (55.55%) cases. 02 
(1.16%) cases presented with peau-d-orange which 
were found to be malignant. Bloody discharge was 
noted in 03 (2.33%) cases.In the present study, out of 
171 cases, 139 (81.28%) cases were epithelial 
proliferative lesions which included those with atypia 
and without atypia, fibrocystic disease (FCC) and 
malignancies. We came across 12 (7.01%) cases of 
acute suppurative mastitis with mean age of 
presentation of 48.4 years, 02 (1.16%) cases of 
lymphocytic mastitis and 04 (2.33%) cases of 
granulomatous mastitis (GM). Two of the GM showed 
foreign body type reaction whereas other two were 
idiopathic. We had 01 (0.58%) case of galactocele in a 
young female. We had 02(1.16%) male patients who 
presented with complaints of vague mass in the breast. 
They were diagnosed as gynecomastia. Epithelial 
proliferative lesion without atypia was noted in 46 
(26.90%) cases. Epithelial proliferative lesion with 
atypia was noted in 14 (8.18%) cases. Among the 
cystic lesions, 07 (4.09%) cases of fibrocystic disease 
were noted. 04 (2.33%) cases showed mild cellular 
atypia, loosely held clusters and sheets and one cell 
population. However criteria for malignancy could not 
be fulfilled, hence, these patients were categorized as 
suspicious for malignancy.[Table1]Amongst all the 
lesions, in contrast to many studies, we came across 62 
(36.25%) cases of positive for malignancy.[ Table 1]. 
Mean age of presentation among epithelial proliferative 
lesion without atypia, with atypia and malignancies 
were25.9 years, 42.9 years and 55.1 years respectively. 
Of the 171 cases, histopathological correlation was 
possible in 111 cases. Of the 62 cases diagnosed 
positive cytologically, one case came back as negative 
on histopathological examination. On statistical 
analysis, our study revealed a high sensitivity and 
specificity of 96.82% and 95.91%, respectively. A 
positive predictive value of 98.38% was noted. 
 
Table 1: Distribution according to diagnosis 
 
Diagnosis No. of cases Percentage 
Acute suppurative inflammation 12 7.01 
Lymphocytic inflammation 02 1.16 
Granulomatous mastitis[GM] 04 2.33 
Galactocele 01 0.58 
Gynecomastia 02 1.16 
Lipoma 07 4.09 
Epithelial proliferative lesion without 
atypia[EPL] 
46 26.90 
Epithelial proliferative lesion with 
atypia[EPLA] 
14 8.18 
Fibrocystic disease[FCC] 07 4.09 
Phyllodes 01 0.58 
Suspicious for malignancy 04 2.33 
Positive for malignancy 62 36.25 
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Unsatisfactory 09 5.26 
Total 171  
 
 
Fig 1: Distribution according to age group affected 
 
 
 
Fig 2: Distribution according to Laterality  
 
 
 
 
Fig 3: Quadrant wise distribution 
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Fig 4: Distribution according to clinical presentation 
 
 
Table 2: Age wise distribution in epithelial proliferative and neoplastic lesion 
 
Age EPL EPLA Phyllodes Lipoma Gynecomastia FCC Suspicious Positive 
<20 16 01 - - - - - - 
21-30 14 04 01 02 1 - - 02 
31-40 10 02 - 03 - 03 01 06 
41-50 03 02 - 02 01 01 02 19 
51-60 - 01 - - - 02 01 18 
61-70 02 03 - - - - - 09 
71-80 01 - - - - 01 - 05 
>81 - 01 - - - - - 03 
Total 46 14 01 07 02 07 04 62 
 
Table 3: Age wise distribution in inflammatory and infectious breast lesions 
 
Age Acute mastitis Lympocytic mastitis Granulomatous mastitis Galactocele 
<20 01 - - - 
21-30 02 01 03 01 
31-40 03 01 01 - 
41-50 05 - - - 
51-60 - - - - 
61-70 01 - - - 
71-80 - - - - 
>81 - - - - 
Total 12 02 04 01 
 
 
Discussion 
 
Martin and Ellis in 1930, first introduced FNAC of 
palpable breast lesions.[7] Ever since, it has proved to 
be an important tool in the diagnosis of palpable breast 
masses. Given the location and morbidity associated 
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with them, breast lesions are a known cause for 
immense anxiety among females. Among the various 
lesions that can occur, pre-malignant and/ or malignant 
lumps specifically are a cause of concern for the 
patients or treating physicians. In this era of improved 
technologies and increasingly applied non-invasive 
diagnostic modalities, FNAC though being minimally 
invasive, it is still preferred in the diagnostic panel of 
palpable breast lumps. Much has been said regarding 
the accuracy and efficacy of this procedure, to the 
extent of decommissioning it as a diagnostic test. 
However, we at our institute are of the opinion that 
FNAC still holds true as a reliable diagnostic arm in 
palpable breast lesions. We performed 171 FNAC 
procedures in our study, of which histopathological 
correlation was possible in 111 cases. Majority of the 
patients were females with 168 (91.64%) cases 
whereas 03 (1.75%) cases were males. The most 
common age group affected was 41-50 years with 
mean age of presentation of 45.4 years. [Table 2, 3] 
Our study was in concordance with one done by Khan 
et al, who also showed the same age group to be 
affected most commonly[8]. Other studies have 
reported the mean age of presentation as 34 years, 32 
years, 59.3 years.[9, 10, 11] Benign lesions had an age 
range of 18-53 years. The mean age of presentation of 
epithelial proliferative lesion without atypia was 25.9 
years. All the malignant cases had an age range from 
28-83 years with most common age group affected 
being 51-60 years seen in 18 (10.52%) cases.[Table 2] 
Mean age of presentation among malignant lesions was 
55.1 years. Khemka et al showed, benign lesions 
occurred mostly in the 30-34 years age group.[12] 
Ganiat et al reported most of the malignant lesions in 
an older age group i.e. 4th - 7th decade[13].  The left 
breast was most commonly affected in our study with 
99 (57.89%) cases and right breast was affected in 69 
(40.35%) cases. Of all the quadrants, the upper outer 
quadrant, with 73 (42.69%) cases, was found to be the 
most frequently affected. Our findings were in 
agreement with studies done by Hussain et al and 
Khemka et al[12, 14]. 
In our study, breast lump with pain was the most 
common presentation with 95 (55.55%) cases. Of the 
171 aspirates, 09 (5.26%) were unsatisfactory. A study 
done by Nguansangiam et al, found the rate of 
unsatisfactory smears to be 4.20 %.[15] Improper 
technique is the most common cause of unsatisfactory 
smears, which was the case in our study. 
We classified the cases as inflammatory with 16 
(9.35%) cases, benign with 64 (37.42%) cases, 
Epithelial proliferative lesion with atypia in 14 (8.18%) 
cases, suspicious for malignancy 04 (2.33%) cases and 
malignancy 62 (36.25%) cases. Among the benign 
lesions, fibroadenoma was the most common lesion to 
be observed with 46 (26.90%) cases. Aslam et al 
showed similar results[16]. We had 62 (36.25%) cases 
of ductal carcinoma of breast, in which 02 were in 
males. Singh et al reported invasive ductal carcinoma 
as the most common breast malignancy[17].  Among 
all the lesions, our study showed a greater prevalence 
of malignancies. This in itself is an unfortunate finding 
as it depicts a steady rise in breast malignancies and its 
pre-malignant conditions. A single case which was 
given positive cytologically, came back as atypical 
ductal hyperplasia histopathologically giving a false 
positive result. Our study showed a sensitivity and 
specificity of 96.82% and 95.91% respectively. 
Positive predictive value was found to be 98.38%. 
Panjvani et al observed a sensitivity of 97.82% and 
specificity of 100%[7].Owing to the rise in pre-
malignant and malignant lesions more so in rural areas 
as seen in our study, there is a need for quick and 
reliable diagnostic investigations which will help in 
reducing the number of the patients lost to follow-up. 
Though, core needle biopsy is a better investigation in 
terms of tissue diagnosis, FNAC has proved to give 
confident diagnoses along with its advantage of being 
economical and having a low tumor seeding incidence 
of 0.0045%[18]. 
 
Conclusion 
 
FNAC is a reliable, cost-effective, patient friendly and 
a quick diagnostic modality especially when employed 
for breast lesions. As observed in our study, a wide 
range of lesion can be diagnosed with good accuracy if 
performed by an experienced hand. Tissue diagnosis is 
the gold standard; however, FNAC along with its 
limitations, over time, has still held its ground firmly. 
FNAC can be relied for the diagnosis of inflammatory, 
pre-malignant and malignant lesions which in effect, 
can reduce morbidity and improve patient care. 
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